Episode Details
Back to Episodes
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
Season 24
Episode 50
Published 4 weeks ago
Description
Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:
- Introduction: Relative Impact of Targeted Treatment (00:00)
- HER2 Alterations (8:04)
- KRAS Mutations (24:25)
- MET Overexpression (30:34)
- ALK Fusions (32:34)
- ROS1 Fusions (42:36)
- RET Fusions (52:00)